NCT06982222 2026-04-13
Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones
National Cancer Institute (NCI)
Phase 1 Not yet recruiting
National Cancer Institute (NCI)
Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd.
University of Tennessee Graduate School of Medicine
University of California, San Diego